The neurothrombectomy devices market was valued at USD 736.35 million in 2024 and is projected to grow from USD 784.58 million in 2025 to USD 1,418.33 million by 2034, exhibiting a CAGR of 6.8% during the 2025–2034 forecast period. The market covers medical devices used to remove blood clots from the brain in patients suffering from acute ischemic stroke. Key trends include the integration of artificial intelligence in stroke management and expanding clinical trials for novel devices. Key players include Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Penumbra, Inc., and Terumo Corporation.

Rising Incidence of Ischemic Strokes

The increasing prevalence of ischemic strokes significantly propels market development. According to the Centers for Disease Control and Prevention, over 795,000 cases of stroke are reported annually in the US, with approximately 87% being ischemic strokes, in which blood flow to the brain is obstructed. This high incidence underscores the need for effective interventions for acute ischemic stroke and drives adoption of neurothrombectomy procedures.

Advances in Mechanical Thrombectomy

Technological advancements in mechanical thrombectomy have enhanced the efficacy and safety of clot removal procedures, contributing to increased utilization. Studies have demonstrated that the approach is safe and effective for acute ischemic stroke, achieving successful blood flow restoration in a significant percentage of cases. These improvements have led to broader acceptance among healthcare professionals and patients, and they continue to support market growth.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/neurothrombectomy-devices-market

Clot Retrievers and Aspiration/Suction Devices

By product, the market is segmented into clot retrievers, aspiration/suction devices, and vascular snares. Clot retrievers dominate the market share owing to their high efficacy in mechanically removing blood clots from cerebral arteries, supported by continuous product innovation by key market players. In 2019, Medtronic launched the Solitaire X revascularization device to enhance the efficiency of clot retrieval procedures.

Aspiration/suction devices are expected to register the highest CAGR during the forecast period because physicians increasingly prefer their ability to vacuum clots out of blood vessels, ensuring accurate revascularization in cases of large vessel occlusion. Vascular snares form the third product category in the report's segmentation.

Regional and Competitive Landscape

North America held the largest market share in 2024, driven by well-established healthcare infrastructure, high stroke prevalence, and the presence of key players investing in research and development. Europe also holds a significant share owing to favorable regulatory support, and the hospitals segment accounted for the largest end-use share in 2024. Asia Pacific is expected to witness the highest CAGR during the forecast period, driven by improving healthcare infrastructure, increasing awareness of stroke management, and a rising aging population susceptible to stroke.

The competitive landscape includes established medical device manufacturers and emerging players focused on innovation. Technological advancements, including next-generation stent retrievers, offer improved clot retrieval efficiency and reduced procedure time. Companies invest in research and development to enhance device efficiency, reduce procedural complications, and improve patient outcomes, while striving for FDA and CE certifications to expand their geographical reach. Medtronic plc, with operational headquarters in Minneapolis, Minnesota, and legal headquarters in Ireland, operates in more than 150 countries and develops devices for cardiac and vascular conditions, diabetes management, and neurological disorders. Stryker Corporation, which operates in over 100 countries, offers neurovascular devices within a diverse product range.

Key Players in the Neurothrombectomy Devices Market

•       Abbott Laboratories

•       Acandis GmbH

•       AngioDynamics, Inc.

•       Argon Medical Devices, Inc.

•       Boston Scientific Corporation

•       Edwards Lifesciences Corporation

•       Johnson & Johnson Services, Inc. (Cerenovus)

•       LeMaitre Vascular, Inc.

•       Medtronic plc

•       MicroVention, Inc. (a subsidiary of Terumo Corporation)

•       Penumbra, Inc.

•       Phenox GmbH

•       Stryker Corporation

•       Terumo Corporation

•       Vesalio, LLC

Conclusion

The neurothrombectomy devices market is set to expand steadily as the burden of ischemic stroke and the effectiveness of clot removal procedures encourage wider adoption. With the market projected to reach USD 1,418.33 million by 2034 at a CAGR of 6.8%, manufacturers that keep investing in product innovation, regulatory approvals, and strategic collaborations are well placed to strengthen their portfolios and enter new markets.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market